{"id":1779,"date":"2018-06-14T12:13:28","date_gmt":"2018-06-14T09:13:28","guid":{"rendered":"http:\/\/ars-patent.co.uk\/cn\/?p=1779"},"modified":"2019-03-12T17:12:27","modified_gmt":"2019-03-12T14:12:27","slug":"kirill-osipov-comments-on-regulation-of-dependent-inventions-in-russia","status":"publish","type":"post","link":"https:\/\/ars-patent.com\/cn\/kirill-osipov-comments-on-regulation-of-dependent-inventions-in-russia\/","title":{"rendered":"Kirill Osipov comments on regulation of dependent inventions in Russia"},"content":{"rendered":"<p style=\"text-align: justify;\"><a href=\"http:\/\/ars-patent.co.uk\/cn\/our-team\/attorneys\/kirill-osipov\/\">Kirill Osipov<\/a>, the Head of Legal Department of ARS-Patent, commented on regulation of dependent inventions in Russia for the newspaper \u201cPharmvestnik\u201d in the light of the Moscow Arbitration Court\u2019s Decision of June 1, 2018, according to which, a first compulsory license may be granted in Russia to a medicament comprising INN Lenalidomide.<\/p>\n<p style=\"text-align: justify;\">More details are available at Pharmvestnik\u2019s <a href=\"https:\/\/pharmvestnik.ru\/publs\/lenta\/v-rossii\/ekspert-institut-zavisimyx-10-6-18.html#.WyERdVUzZUQ\" target=\"_blank\" rel=\"noopener\">website<\/a>.<\/p>\n<p style=\"text-align: justify;\">Pharmvestnik is the leading specialized weekly newspaper covering the Russian pharmaceutical and related industries with a circulation of 16 200 copies. The newspaper has been issued since 1994.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kirill Osipov, the Head of Legal Department of ARS-Patent, commented on regulation of dependent inventions in Russia for the newspaper \u201cPharmvestnik\u201d in the light of the Moscow Arbitration Court\u2019s Decision of June 1, 2018, according to which, a first compulsory license may be granted in Russia to a medicament comprising INN Lenalidomide. More details are [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[18],"tags":[],"post-type":[12],"class_list":["post-1779","post","type-post","status-publish","format-standard","hentry","category-litigation","post-type-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/ars-patent.com\/cn\/wp-json\/wp\/v2\/posts\/1779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ars-patent.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ars-patent.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ars-patent.com\/cn\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ars-patent.com\/cn\/wp-json\/wp\/v2\/comments?post=1779"}],"version-history":[{"count":2,"href":"https:\/\/ars-patent.com\/cn\/wp-json\/wp\/v2\/posts\/1779\/revisions"}],"predecessor-version":[{"id":1872,"href":"https:\/\/ars-patent.com\/cn\/wp-json\/wp\/v2\/posts\/1779\/revisions\/1872"}],"wp:attachment":[{"href":"https:\/\/ars-patent.com\/cn\/wp-json\/wp\/v2\/media?parent=1779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ars-patent.com\/cn\/wp-json\/wp\/v2\/categories?post=1779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ars-patent.com\/cn\/wp-json\/wp\/v2\/tags?post=1779"},{"taxonomy":"post-type","embeddable":true,"href":"https:\/\/ars-patent.com\/cn\/wp-json\/wp\/v2\/post-type?post=1779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}